This compound was initially solubilized in 98% ethanol, sterilized using 0.2 μm filters, added to 45°C YEM medium, and homogenized to obtain a final concentration of 0,2 g.l-1 of PCNB into the P-YEM medium.
The fourth sentence in the section Formulation and evaluation of the selective medium "This compound was initially solubilized in 98% ethanol, sterilized using 0.2 μm filters, added to 45°C YEM medium, and homogenized to obtain a final concentration of 0,2 g.l-1 of PCNB into the P-YEM medium".
The first reported such compound was initially characterized as ·nH2O in 1968, but was suggested in 1973 to actually have the formula ·2H2O based on the fact that Np VII) occurs as in aqueous solution.
However, this compound was initially identified in a phenotype-based reporter-gene assay and, although additional studies have indicated TTSS specificity, the target protein is still unknown [39].
Each compound was initially docked and then ranked by the predicted binding energy to obtain the line values in the network.
Thus, according to KEGG nomenclature, the labels Phosphorylation, Dephosphorylation, Indirect, Expression and Compound are initially considered activations, unless the contrary is specified.
The compound was initially misidentified as C60F18CF2, but in the follow-up publication by the same group it was correctly identified as a mixture of C s - and C1-C60F17 CF3) (C s -C60F17(C2F5) was also isolated).
This compound was initially designed to compensate for a deficit in the natural anticoagulant protein C during sepsis, and thus it limited organ failures and improved the survival of septic shock patients [ 96].
The library of compounds is initially selected based on docking to the antiparallel β-sheet of Aβ16 21.
Compounds were initially standardized using Chemaxon Standardizer [40], to ensure a consistent representation of compounds.
